<DOC>
	<DOCNO>NCT02678611</DOCNO>
	<brief_summary>This study investigate safety , tolerability potential health benefit dietary supplement , Basis . There two dos Basis compare placebo . One third subject receive low dose Basis , one third receive high dose Basis one third receive placebo .</brief_summary>
	<brief_title>A Study Evaluate Safety Health Benefits Basis™ Among Elderly Subjects .</brief_title>
	<detailed_description />
	<criteria>Males females 60 80 ( inclusive ) year age Body Mass Index ( BMI ) must 18 35 kg/ m2 ( ±1 kg/m2 ) •Be able make schedule office visit 4 time study Willing follow instruction complete multiple study questionnaires assessment Agrees avoid take Vitamin B3 ( Niacin , Nicotinic acid niacinamide ) supplement multivitamins 14 day prior randomization duration study period Healthy otherwise determine laboratory result medical history Has give voluntary , write , inform consent participate study History significant chronic disease clinically active illness within 3 month study entry , include history renal liver impairment , endocrine , inflammatory , cardiovascular , gastrointestinal , neurological , psychiatric , neoplastic metabolic disease . Clinical significance disease assess Qualified Investigator eligibility determine . Significant untreated medical disorder include recent myocardial ischemia infarction , unstable angina , uncontrolled hypertension , AIDS , malignancy , epilepsy , recent cerebrovascular disease Subjects recently experience traumatic injury , infection undergo surgery Subjects history pellagra niacin deficiency Taking lipid lower drug Use natural health product contain Nicotinamide riboside within 14 day prior randomization course study History current diagnosis cancer ( except successfully treat basal cell carcinoma ) diagnose less 5 year prior screen . Volunteers cancer full remission 5 year diagnosis acceptable Has participate clinical trial investigational medicinal product within past three month prior first dose current study Unstable medical condition Alcohol use &gt; 2 standard alcoholic drink per day History alcoholism drug abuse within 1 year prior screen History significant allergy Allergy sensitivity investigational product ingredient Use medicinal marijuana Clinically significant abnormal laboratory result screen Individuals cognitively impair and/or unable give inform consent Any condition Investigator 's opinion may adversely affect participant 's ability complete study measure may pose significant risk participant</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Healthy participant</keyword>
	<keyword>Dietary supplement</keyword>
	<keyword>Safety</keyword>
	<keyword>Tolerability</keyword>
	<keyword>Older Adults</keyword>
	<keyword>Basis</keyword>
	<keyword>Nicotinamide riboside</keyword>
	<keyword>Pterostilbene</keyword>
</DOC>